Receive Promise magazine online to learn about the innovative research and excellent medical care happening at St. Jude. Your free subscription will start with our next quarterly issue of Promise.
In this issue . . .
Paws at Play: A Message from Puggle
Therapy dogs in the St. Jude Paws at Play program make the day a little easier for patients—whether helping them relax during procedures, demonstrating how to take medicine or climbing on a mock scanner to show them MRIs aren’t scary.
An Added Boost for Medulloblastoma: SJELIOT
SJELIOT, a St. Jude-led clinical trial for medulloblastoma, tests prexasertib, a drug that enhances the power of other chemotherapies.
Scientists Collaborate to Create a Lattice Light-Sheet Microscope
To build a next-generation lattice light-sheet microscope, St. Jude neurobiologists work with a Nobel laureate and a select team of scientists.
Cancer Survivors Build Bridge to a Healthy Future
St. Jude helps childhood cancer survivors take control of their health by building lifelong relationships with their primary care providers.
Minds Over Matter: St. Jude Research Collaboratives
The St. Jude Research Collaboratives unite global experts from many different institutions to answer outstanding scientific questions.
Soft Landings with the Transition Oncology Program
The new Transition Oncology Program (TOP) provides support and education to families whose children are returning home after cancer therapy.
LANDO Discovery Has Implications for Cancer Immunotherapy and Alzheimer’s Disease
Activating LANDO, or LC3-associated endocytosis, appears to offer protection against neurodegenerative disease and guard against toxic neuroinflammation and neurodegeneration, including memory problems.
Sharing Data Worldwide
St. Jude is helping drive a new age of information-sharing, providing a roadmap for investigators complete with data, tools and resources. By using sophisticated technology, St. Jude shares this data with the global community.
Life after St. Jude: We are the Champions
Everyone wins when childhood cancer survivors volunteer to help tomorrow’s patients through St. Jude LIFE, the hospital’s long-term follow-up study.
R is for Robot: Automating Drug Screening
Scientists in the High-Throughput Bioscience Center use robots to automate the screening of hundreds of thousands of compounds to discover potential new drugs.
News & Highlights - Winter 2020
Learn about the latest discoveries and achievements at St. Jude: the structure of chaperones, flu vaccine news, exercise benefits, TOTAL 16 clinical trial for leukemia, 3D map of the genome, and more.